Posts

October 16, 2014

+
12:55 PM | FDA Guidance Discusses UDI Labeling Requirements For Small Medical Device Manufacturers
A new guidance document intended to assist small medical device manufacturers is now available from the FDA. ‘Unique Device Identification System: Small Entity Compliance Guide” consists of a series of recommendations designed to help companies handle the requirements associated with the UDI system and Global Unique Device Identification Database (GUDID). The document is intended as ... continue reading
+
12:20 PM | What’s The Answer? (transmembrane protein dbs)
Biostars is a site for asking, answering and discussing bioinformatics questions and issues. We are members of the community and find it very useful. Often questions and answers arise at Biostars that are germane to our readers (end users of genomics resources). Every Thursday we will be highlighting one of those items or discussions here […]
+
11:15 AM | Biotech / Pharma / Drug Development Journal Watch
Artificial sweeteners induce glucose intolerance by altering the gut microbiotaSuez et al. Nature.Patient-Contributed Tumor Genetics Data: A Pathway to Better Drug DevelopmentBenita et al. AJMC.Reversion of advanced Ebola virus disease in nonhuman primates with ZMappQiu et al. Nature.Ice bucket challenge cash may help derisk ALS drug researchManasi Vaidya. Nature Medicine.Development of the clinical next-generation sequencing industry in a shifting policy climateCurnutte et al. Nature […]
+
10:23 AM | Strong sales in breast cancer lift Roche revenues
New products Perjeta and Kadcyla lead growth
+
10:13 AM | AbbVie board recommends dropping Shire deal
Tells stakeholders to vote against merger in light of new rules on corporate tax
+
10:12 AM | AstraZeneca cements links with Cambridge University
Agrees a series of collaborations in areas such as Alzheimer's and multiple sclerosis

October 15, 2014

+
11:31 PM | Eisai launches online breast cancer resource
Website includes information on the disease, treatment options and side effects
+
11:30 PM | Galapagos appoints Bart Filius as chief financial officer
He joins from Sanofi where he was CFO for Europe
+
11:02 PM | Using video as part of a healthcare marketing strategy
Information and entertainment are not mutually exclusive in the moving image
+
8:33 PM | Exercise benefit is in your genes
People who are unfit – who have low maximal oxygen consumption or low aerobic capacity – are at an increased risk for early death. Unfortunately, exercise won’t fix this for everybody. Some people become much fitter after endurance training, but 20% of us don’t respond at all. And how fit you are before training doesn’t […]
+
4:41 PM | EMA expands adverse event reporting website
Opens it up to all nationally-authorised medicines
+
3:40 PM | Choosing Your Subcloning Strategy
Before you begin your subcloning, you need to know: The restriction enzyme (RE) sites available for subcloning in your parent vector multiple cloning region (or in the insert if you need to digest the insert); the RE sites available in the destination vector multiple cloning region (MCR); and if these same sites also occur in […]
+
3:00 PM | Artificial Transcription Factors – A new class of epigenetic drug
Aberrant epigenetic status resulting in dysregulation of gene expression is a hallmark of many cancers and other diseases. In the last decade, countless time and energy has been spent in efforts to develop drugs targeting DNA methylation and histone modifications. To date however, none of these epigenetic drugs are sequence ... The post Artificial Transcription Factors – A new class of epigenetic drug appeared first on EpiBeat.
+
1:46 PM | Video Tip of the Week: MedGen, GTR, and ClinVar
The terrific folks at NCBI have been increasing their outreach with a series of webinars recently. I talked about one of them not too long ago, and I mentioned that when I found the whole webinar I’d highlight that. This recording is now available, and if you are interested in using these medical genetics resources, […]

Acland A., R. Agarwala, T. Barrett, J. Beck, D. A. Benson, C. Bollin, E. Bolton, S. H. Bryant, K. Canese, D. M. Church & K. Clark (2013). Database resources of the National Center for Biotechnology Information, Nucleic Acids Research, 42 (D1) D7-D17. DOI: http://dx.doi.org/10.1093/nar/gkt1146

Citation
+
1:22 PM | 25 Hilarious Ig Nobel Prizes
The Ig Nobel Prize was established in the year 1990 to “celebrate the unusual, honor the imaginative — and spur people’s interest in science, medicine, and technology.” The official ceremony is a lot of fun and it is great to see serious scientists having a blast all in the name of science. In honor of […]
+
10:40 AM | Rifiuti elettronici, cresce il riciclo dei piccoli elettrodomestici: +10%
Il consorzio Ecolight: «Nei primi nove mesi dell’anno è aumentata l’attenzione verso il corretto conferimento di cellulari, frullatori e pc, RAEE che sono difficili da intercettare. I dati dimostrano perciò che è cresciuta la sensibilità ambientale»Read more →
+
10:28 AM | AbbVie rethinks Shire merger in light of US tax crackdown
Follows action to discourage 'inversion deals' aimed at reducing corporate tax rates
+
10:17 AM | Generic drugs restricting market growth in Netherlands
GlobalData says Government focus on cheap copies is impacting industry
+
10:04 AM | Russian HIV vaccine heading for phase II trials
But trials could be affected by lack of funding
+
9:49 AM | Olysio drives J&J pharma sales
But hepatitis C drug set to face serious competition from Gilead Sciences
+
9:37 AM | SMC recommends Novartis’ Gilenya for severe form of MS
Leads wave of drug reimbursement opinions in Scotland

October 14, 2014

+
11:30 PM | Ashley Communications appoints Sarah Savage as director
She joins from WCG London
+
11:15 PM | Pharmacy Voice names head of comms
Melissa Fife joins from Forster Communications
+
11:02 PM | Changing behaviour with fast and slow thinking
Challenging the decision-making that underpins behaviour change
+
3:59 PM | US approval for Philips' telehealth applications
The programmes give clinicians real-time access to health data
+
1:09 PM | Update from the Clinic: September
. Welcome to your Update from the Clinic for the month of September. There’s a mixture of news from the cancer stem cell companies and immunotherapy companies this past month. Amongst other things, the FDA removed the previously imposed partial hold on one of OncoMed’s therapeutics; Opexa Therapeutics announced its next therapeutic program; and, Harvard...Read more
+
12:55 PM | FDA Issues Guidance on Generics Controlled Correspondence
On August 26, 2014, FDA published a draft Guidance for Industry entitled “Controlled Correspondence Related to Generic Drug Development”.  FDA defines Controlled Correspondence as follows: “A correspondence submitted to the Agency, by or on behalf of a generic drug manufacturer or related industry, requesting information on a specific element of generic drug product development”. Under ... continue reading
+
11:33 AM | NICE working to tackle antimicrobial resistance
Two guidelines in development to improve NHS use of antibiotic drugs
+
10:05 AM | Pfizer's palbociclib on track for early 2015 launch
Good news for the highly anticipated breast cancer drug
+
9:35 AM | BMS and Janssen to assess PD1 cancer combination
Will test Opdivo and Imbruvica in non-Hodgkin lymphoma
123456789
322 Results